Product Safety Recalls

Product Recall Tracker

TOBRAMYCIN SULFATE Recall D-0385-2024

Description: Tobramycin for Injection, USP, 1.2 grams per Pharmacy Bulk Package, Rx Only, For Intravenous Use, PHARMACY BULK PACKAGE NOT FOR DIRECT INFUSION, Mfd. in India for: Eugia US LLC, E. Windsor, NJ 08520, Carton NDC 55150-470-06, Vial NDC 55150-470-01.

TOBRAMYCIN SULFATE Recall D-0385-2024 Information

StatusOngoing
Mandated?Voluntary: Firm initiated
Recall NumberD-0385-2024
Event ID94081
BrandTOBRAMYCIN
Generic NameTOBRAMYCIN
ManufacturerTOBRAMYCIN
Original Package?1
Active SubstanceTOBRAMYCIN SULFATE
Drug RouteINTRAVENOUS
DistributionNationwide
Quantity1160 VIALS
Recall ReasonFailed Stability Specification: Water determination was found not complying with specification.
Drug ClassificationClass II
Drug Code Info20240320
Product NDC55150-470
Drug UPC0355150470013
Recall Initiation Date20240222
Report Date20240320
Classification Date20240314
Address279 Princeton Hightstown Rd
East Windsor, NJ 08520-1401
United States
Recalling FirmEugia US LLC
Initial Notification Letter
Unique Ingredient IdentifierHJT0RXD7JK
Drug Application NumberANDA217519
Structured Product Labeling (SPL ID)c37c251f-92e9-40f0-8b0c-00d42875d776
Structured Product Labeling (SPL Set ID)c37c251f-92e9-40f0-8b0c-00d42875d776
Similar To

© 2022 Recall.Report / Contact / Privacy Policy

This site's data is aggregated programmatically and provided "as is" without any representations or warranties, express or implied.
Recall.report is not affiliated with the Consumer Product Safety Commision, FDA, or US government in any way.